Insider Transactions Reported by 22 Insiders of Terns Pharmaceuticals, Inc.

Symbol
TERN on Nasdaq
Location
Foster City, CA

Insiders trading volume in the past year

Terns Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Opportunity, LLC 10%+ Owner $38,671,440 01 Apr 2024
Amy L. Burroughs Chief Executive Officer, Director $11,180,084 -$5,176,603 -32% 14 Jan 2026
ORBIMED ADVISORS LLC Director, 10%+ Owner $7,556,350 15 Jul 2024
CARL L. GORDON Director, 10%+ Owner $7,556,350 15 Jul 2024
Hongbo Lu Director $4,999,995 11 Jun 2025
Emil Kuriakose Chief Medical Officer $4,307,246 -$57,965 -1.3% 14 Jan 2026
Andrew Gengos Chief Financial Officer $4,112,235 +$96,366 +2.4% 14 Jan 2026
LAV Biosciences Fund V, L.P. 10%+ Owner $2,002,500 23 Nov 2022
David Strauss Principal Accounting Officer $519,682 01 Feb 2025
Mark J. Vignola Chief Financial Officer $433,210 02 Jan 2025
Seokho Bryan Yoon COO and General Counsel $408,214 31 May 2024
Erin Quirk President, Head of R&D $283,500 23 Jan 2024
Senthil Vel Sundaram Chief Executive Officer, Director $36,931 31 May 2023
Melita Sun Jung Chief Business Officer $11,498 30 Jan 2025
Jill M. Quigley Director $0 -$441,360 -100% 04 Nov 2025
Heather D. Turner Director 11 Jun 2025
Robert Azelby Director 20 Feb 2025
DAVID A. FELLOWS Director 11 Jun 2025
JEFFREY B. KINDLER Director 11 Jun 2025
Radhika Tripuraneni Director 11 Jun 2025
Ann Elizabeth Taylor Director 01 Jul 2024
Kerry Strong Russell Chief Medical Officer 01 Jul 2022

Recent Insider Transactions by Companies or Individuals for Terns Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.